Detalhe da pesquisa
1.
Genetic architecture of plasma Alzheimer disease biomarkers.
Hum Mol Genet
; 32(15): 2532-2543, 2023 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37208024
2.
Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson's disease.
Acta Neuropathol
; 147(1): 52, 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38467937
3.
Alzheimer's polygenic risk scores are associated with cognitive phenotypes in Down syndrome.
Alzheimers Dement
; 20(2): 1038-1049, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37855447
4.
TOPMed imputed genomics enhances genomic atlas of the human proteome in brain, cerebrospinal fluid, and plasma.
Sci Data
; 11(1): 387, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38627416
5.
Systematic proteomics in Autosomal dominant Alzheimer's disease reveals decades-early changes of CSF proteins in neuronal death, and immune pathways.
medRxiv
; 2024 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38260583
6.
Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's disease.
Mol Neurodegener
; 19(1): 1, 2024 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38172904
7.
Unique genetic architecture of CSF and brain metabolites pinpoints the novel targets for the traits of human wellness.
Res Sq
; 2023 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37333177
8.
Proteome wide association studies of LRRK2 variants identify novel causal and druggable proteins for Parkinson's disease.
NPJ Parkinsons Dis
; 9(1): 107, 2023 Jul 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37422510
9.
Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and informs causal proteins for Alzheimer's disease.
Res Sq
; 2023 Jun 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37333337
10.
Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease.
Acta Neuropathol Commun
; 11(1): 68, 2023 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37101235
11.
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning.
Genome Med
; 15(1): 79, 2023 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794492
12.
Gene co-expression changes underlying the functional connectomic alterations in Alzheimer's disease.
BMC Med Genomics
; 15(Suppl 2): 92, 2022 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35461274
13.
Integrative analysis of eQTL and GWAS summary statistics reveals transcriptomic alteration in Alzheimer brains.
BMC Med Genomics
; 15(Suppl 2): 93, 2022 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35461270